The consequences of underreporting are significant and multifaceted. For one, it skews epidemiological data, making it difficult to identify trends and allocate resources effectively. Additionally, it hampers public health initiatives aimed at prevention and early detection. Without accurate data, policies and programs designed to combat cancer may be less effective. Furthermore, underreporting can affect funding and research priorities, leading to gaps in our scientific understanding of the disease.